Indo Us Biotech Limited has informed the Exchange about Copy of Newspaper Publication relating to the Unaudited Quarterly Standalone Financial Results for the quarter ended on 31st December, 2025.
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has submitted to the NSE a copy of the newspaper advertisement in which it published its unaudited standalone financial results for the quarter ended 31st December 2025 (Q3 FY26). This is a routine compliance filing under SEBI listing rules, which require listed companies to publish a summary of their quarterly results in at least one English and one regional language newspaper. No new financial numbers are introduced in this filing — the actual results would have been filed separately with the exchange earlier. The publication simply fulfills the public disclosure requirement.
No new material impact for shareholders — this is a procedural regulatory submission and does not change the company's financial position or outlook. Investors should refer to the original quarterly results filing for actual numbers.